Veradigm Inc. Cash Flow Conversion Efficiency

Latest as of September 2022: 0.024x

Veradigm Inc. cash flow conversion efficiency. Based on the latest financial reports, Veradigm Inc. (MDRX) has a cash flow conversion efficiency ratio of 0.024x as of September 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($28.14 Million) by net assets ($1.18 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Veradigm Inc. (1998–2024)

Cash flow conversion efficiency of Veradigm Inc. from 1998 to 2024. This chart illustrates how Veradigm Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View Veradigm Inc. stock quote for real-time trading data and today's change.

Veradigm Inc. Cash Flow Conversion Ratio Explained

Veradigm Inc. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Veradigm Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Veradigm Inc. ranked by their cash flow conversion efficiency. Also see MDRX market cap for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Kofola CeskoSlovensko as
PR:KOFOL
0.222x
YaGuang Technology Group Co Ltd
SHE:300123
-0.035x
Hansen Technologies Ltd
AU:HSN
0.164x
Shandong Longhua New Material Co. Ltd.
SHE:301149
0.012x
4D Molecular Therapeutics Inc
NASDAQ:FDMT
0.056x
Ethan Allen Interiors Inc
NYSE:ETD
0.048x
Shanghai New Centurion Network Information Technology Co Ltd
SHG:605398
0.016x
Hefei Taihe Optoelectronic
SHG:603656
0.052x

Annual Cash Flow Conversion Efficiency for Veradigm Inc. (1998–2024)

The table below shows the annual cash flow conversion efficiency of Veradigm Inc. from 1998 to 2024. Review MDRX free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $1.02 Billion $115.56 Million 0.114x 0.00%
2022-12-31 $1.02 Billion $115.56 Million 0.114x +312.03%
2021-12-31 $1.41 Billion $-75.43 Million -0.054x +16.36%
2020-12-31 $1.67 Billion $-106.72 Million -0.064x -277.95%
2019-12-31 $1.29 Billion $46.25 Million 0.036x -16.23%
2018-12-31 $1.58 Billion $67.90 Million 0.043x -75.53%
2017-12-31 $1.59 Billion $279.42 Million 0.176x +8.39%
2016-12-31 $1.66 Billion $269.00 Million 0.162x +8.62%
2015-12-31 $1.42 Billion $211.58 Million 0.149x +85.01%
2014-12-31 $1.28 Billion $103.50 Million 0.081x +31.16%
2013-12-31 $1.32 Billion $80.99 Million 0.061x -64.56%
2012-12-31 $1.28 Billion $222.67 Million 0.173x -4.74%
2011-12-31 $1.48 Billion $268.75 Million 0.182x +80.01%
2010-12-31 $1.38 Billion $139.90 Million 0.101x -49.39%
2009-12-31 $700.40 Million $139.92 Million 0.200x +287.81%
2008-12-31 $700.37 Million $36.08 Million 0.052x 0.00%
2007-12-31 $700.37 Million $36.08 Million 0.052x -40.57%
2006-12-31 $316.25 Million $27.41 Million 0.087x -48.32%
2005-12-31 $98.42 Million $16.51 Million 0.168x +6.04%
2004-12-31 $78.69 Million $12.45 Million 0.158x +153.41%
2003-12-31 $83.39 Million $5.21 Million 0.062x +149.74%
2002-12-31 $85.82 Million $-10.77 Million -0.125x +62.45%
2001-12-31 $98.63 Million $-32.96 Million -0.334x -289.26%
2000-12-31 $290.98 Million $-24.98 Million -0.086x +54.44%
1999-12-31 $67.40 Million $-12.70 Million -0.188x +74.43%
1998-12-31 $5.70 Million $-4.20 Million -0.737x --

About Veradigm Inc.

NASDAQ:MDRX USA Health Information Services
Market Cap
$527.79 Million
Market Cap Rank
#11692 Global
#3000 in USA
Share Price
$4.85
Change (1 day)
+5.46%
52-Week Range
$4.20 - $5.18
All Time High
$23.09
About

Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising practice management software, AI patient scheduling software, and electronic statements and payments, and payerpath clearinghouse; revenue cycle se… Read more